US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kenvue Inc

22.33

-1.2900-5.46%

Post-market: 22.18-0.1499-0.67%19:44 EDT

Volume:17.77M

Turnover:402.64M

Market Cap:42.68B

PE:41.52

High:23.78

Open:23.67

Low:22.27

Close:23.62

Loading ...

Overview Company News Filings

There May Be Reason For Hope In Kenvue's (NYSE:KVUE) Disappointing Earnings

Simply Wall St.

3 US Stocks Estimated Up To 31.4% Below Intrinsic Value

Simply Wall St.

Kenvue Third Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

Bank of America Securities Sticks to Its Buy Rating for Kenvue, Inc. (KVUE)

New Buy Rating for Kenvue, Inc. (KVUE), the Technology Giant

Kenvue Inc (KVUE) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Market Challenges

FDA proposes removing oral decongestant phenylephrine from OTC meds

Kenvue Inc. (KVUE): Expanded Production and Trusted Brands Drive Growth

Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales

Kenvue Inc reports results for the quarter ended in September 30 - Earnings Summary

Band-Aid, Tylenol parent's sales miss the mark amid weakness in skin health

Kenvue Exec Says External Environment Is "Certainly Not Helping" Skin Health Unit Recovery

THOMSON REUTERS

Kenvue Exec Says in Skin Health Category, Whole Industry Is Seeing That the Consumer Remains Cautious in China - Conf Call

THOMSON REUTERS

Kenvue (KVUE) Q3 Earnings Surpass Estimates

Kenvue's Q3 Adjusted Earnings, Net Sales Decline

MT Newswires Live

Kenvue Inc (KVUE) Q3 2024 Earnings: EPS at $0.20 Misses Estimates, Revenue Slightly Below Expectations at $3.9 Billion

Band-Aid, Tylenol parent tops profit view, but sales fall a bit shy and outlook was trimmed

Band-Aid, Tylenol Parent Tops Profit View, But Sales Fall A Bit Shy And Outlook Was Trimmed -- MarketWatch

Kenvue Expects 2024 Net Sales Growth And Organic Growth Toward The Low End Of Its Outlook Of 1.0%-3.0% And 2.0%-4.0%, Respectively, Reaffirms 2024 Adjusted EPS Of $1.10-$1.20 Versus Consensus Of $1.14

Kenvue Q3 2024 Adj EPS $0.28 Beats $0.27 Estimate, Sales $3.90B Miss $3.93B Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KVUE/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KVUE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KVUE\",,,,,undefined,":{"symbol":"KVUE","market":"US","secType":"STK","nameCN":"Kenvue Inc","latestPrice":22.33,"timestamp":1743796800000,"preClose":23.62,"halted":0,"volume":17771415,"hourTrading":{"tag":"盘后","latestPrice":22.1801,"preClose":22.33,"latestTime":"19:44 EDT","volume":1686362,"amount":37656423.0377,"timestamp":1743810284367},"delay":0,"floatShares":1908459482,"shares":1911240720,"eps":0.537859,"marketStatus":"Market Closed","change":-1.29,"latestTime":"04-04 16:00:00 EDT","open":23.67,"high":23.78,"low":22.27,"amount":402635344.921005,"amplitude":0.063929,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.537859,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"listingDate":1683172800000,"exchange":"AMEX","adjPreClose":23.62,"dividendRate":0.036274,"preHourTrading":{"tag":"盘前","latestPrice":23.7,"preClose":23.62,"latestTime":"09:29 EDT","volume":166585,"amount":3934826.489805,"timestamp":1743773371097},"postHourTrading":{"tag":"盘后","latestPrice":22.1801,"preClose":22.33,"latestTime":"19:44 EDT","volume":1686362,"amount":37656423.0377,"timestamp":1743810284367},"volumeRatio":1.143988,"impliedVol":0.3369,"impliedVolPercentile":0.7649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KVUE\",,,,,undefined,":{"symbol":"KVUE","floatShares":1908459482,"roa":"6.88%","roe":"9.87%","lyrEps":0.537859,"volumeRatio":1.143988,"shares":1911240720,"dividePrice":0.81,"high":23.78,"amplitude":0.063929,"preClose":23.62,"low":22.27,"week52Low":17.67,"pbRate":"4.41","psRate":"2.76","week52High":24.46,"institutionHeld":0,"latestPrice":22.33,"eps":0.537859,"divideRate":0.036274,"volume":17771415,"delay":0,"ttmEps":0.537859,"open":23.67,"prevYearClose":21.35,"prevWeekClose":23.7,"prevMonthClose":23.98,"prevQuarterClose":23.98,"fiveDayClose":23.7,"twentyDayClose":23.42,"sixtyDayClose":21.05},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KVUE\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2483303359","title":"There May Be Reason For Hope In Kenvue's (NYSE:KVUE) Disappointing Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2483303359","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483303359?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:33","pubTimestamp":1731681238,"startTime":"0","endTime":"0","summary":"Kenvue Inc.'s  recent soft profit numbers didn't appear to worry shareholders, as the stock price showed strength. Our analysis suggests that investors may have noticed some promising signs beyond the statutory profit figures.NYSE:KVUE Earnings and Revenue History November 15th 2024. For anyone who wants to understand Kenvue's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$1.0b due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If Kenvue doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.That might leave you wondering what analysts are forecasting in terms of","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_kZOVgp9mzpLivYgIet9SA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_kZOVgp9mzpLivYgIet9SA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/may-reason-hope-kenvues-nyse-143358962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KVUE","HOPE","NYSE"],"gpt_icon":0},{"id":"2482886204","title":"3 US Stocks Estimated Up To 31.4% Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2482886204","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482886204?lang=en_us&edition=fundamental","pubTime":"2024-11-11 18:07","pubTimestamp":1731319624,"startTime":"0","endTime":"0","summary":"As the U.S. stock market continues to reach record highs, fueled by a post-election rally and optimism surrounding potential policy changes, investors are keenly focused on identifying opportunities that may still be undervalued amidst this bullish environment. In such a thriving market, finding stocks trading below their intrinsic value can offer significant potential for growth as these companies may not yet reflect their full worth in the current pricing landscape.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Corpay is trading at 26.3% below its estimated fair value, highlighting potential undervaluation based on cash flows. The company reported third-quarter sales of US$1.03 billion, with net income rising to US$276.4 million, and it has increased its share repurchase program by US$1 billion. Despite high debt levels and recent insider selling, Corpay's earnings are forecast to grow faster than the overall U.S. market at 15.5% annually, supported by strategic ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_kZOVgp9mzpLivYgIet9SA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_kZOVgp9mzpLivYgIet9SA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-us-stocks-estimated-31-100704610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDE","KVUE","LU0820561909.HKD","LU1069344957.HKD","BK4500","BK4516","LU0820561818.USD","LU0823416689.USD","LU0238689110.USD","IE0004445239.USD","LU0203202063.USD","BK4581","LU0320765059.SGD","BK4588","IE00BJJMRZ35.SGD","LU0106261372.USD","LU0640476718.USD","LU0122379950.USD","BK4227","LU0882574055.USD","LU0943347566.SGD","IE00BK4W5M84.HKD","LU0882574139.USD","IE00BJLML261.HKD","LU0097036916.USD","IE0002141913.USD","GB00BDT5M118.USD","LU0354030511.USD","LU1633808545.USD","LU1064131342.USD","BK4534","LU0198837287.USD","LU0256863811.USD","LU0672654240.SGD","LU0708995401.HKD","BK4017","IE00BK4W5L77.USD","LU0471298777.SGD","ALK","CPAY","LLY","LU0006306889.USD","LU0385154629.USD","IE00B1BXHZ80.USD","BK4008","LU0466842654.USD","LU0256863902.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0079474960.USD","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2482698802","title":"Kenvue Third Quarter 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2482698802","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482698802?lang=en_us&edition=fundamental","pubTime":"2024-11-10 21:26","pubTimestamp":1731245203,"startTime":"0","endTime":"0","summary":"NYSE:KVUE Earnings and Revenue Growth November 10th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 16%.Looking ahead, revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Personal Products industry in the US.The company's shares are up 4.2% from a week ago.We should say that we've discovered 4 warning signs for Kenvue (1 doesn't sit too well with us!) that you should be aware of before investing here.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kenvue-third-quarter-2024-earnings-132643229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KVUE"],"gpt_icon":1},{"id":"2481255104","title":"Bank of America Securities Sticks to Its Buy Rating for Kenvue, Inc. (KVUE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481255104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481255104?lang=en_us&edition=fundamental","pubTime":"2024-11-08 22:52","pubTimestamp":1731077557,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Anna Lizzul maintained a Buy rating on Kenvue, Inc. (KVUE – Research Report) today. The company’s shares opened ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-its-buy-rating-for-kenvue-inc-kvue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-its-buy-rating-for-kenvue-inc-kvue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KVUE"],"gpt_icon":0},{"id":"2481410664","title":"New Buy Rating for Kenvue, Inc. (KVUE), the Technology Giant","url":"https://stock-news.laohu8.com/highlight/detail?id=2481410664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481410664?lang=en_us&edition=fundamental","pubTime":"2024-11-08 22:16","pubTimestamp":1731075374,"startTime":"0","endTime":"0","summary":"In a report released today, Keith Devas from Jefferies maintained a Buy rating on Kenvue, Inc. (KVUE – Research Report), with a price target of $27...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/new-buy-rating-for-kenvue-inc-kvue-the-technology-giant-9?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/new-buy-rating-for-kenvue-inc-kvue-the-technology-giant-9?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KVUE"],"gpt_icon":0},{"id":"2481436149","title":"Kenvue Inc (KVUE) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Market Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2481436149","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481436149?lang=en_us&edition=fundamental","pubTime":"2024-11-08 15:11","pubTimestamp":1731049894,"startTime":"0","endTime":"0","summary":"Adjusted Gross Margin Expansion: 130 basis points to 60.7%.Skin Health and Beauty Organic Sales Decline: 2.7%.Net Interest Expense: $96 million for the quarter.Adjusted Effective Tax Rate: 28.9% for the quarter.Adjusted Net Income: $542 million for the quarter.Full Year Organic Growth Expectation: Towards the low end of 2% to 4% range.GuruFocus has detected 7 Warning Signs with LGND.Kenvue Inc  delivered year-over-year organic growth of 0.9% in Q3 2024, despite a softer top line.Kenvue Inc  is on track to invest approximately 20% more in marketing in 2024, focusing on social media and analytics-driven strategies.Kenvue Inc  is implementing a new playbook to strengthen its market presence, with early positive results in self-care and essential health segments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kenvue-inc-kvue-q3-2024-071134765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KVUE"],"gpt_icon":0},{"id":"2481530061","title":"FDA proposes removing oral decongestant phenylephrine from OTC meds","url":"https://stock-news.laohu8.com/highlight/detail?id=2481530061","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481530061?lang=en_us&edition=fundamental","pubTime":"2024-11-08 03:44","pubTimestamp":1731008697,"startTime":"0","endTime":"0","summary":"Joe Raedle/Getty Images News The U.S. FDA is proposing issuing an order that would remove the oral decongestant phenylephrine from many over-the-counter cough and cold medicines as a review has found the drug ineffective. The agency said that a comprehensive evaluation examined data from decades ago used to support oral phenylephrine's initial approval as well as newer data. Other formulations of phenylephrine are not impacted.   Oral phenylephrine is found in many popular OTC cough and cold remedies including Kenvue's  Sudafed, Procter & Gamble's  DayQuil and NyQuil, and Haleon's  Robitussin and Triaminic. The FDA's proposed order is not a surprise considering an advisory committee in September 2023 voted that oral phenylephrine lacks effectiveness. The following month, CVS Health  pulled products containing oral phenylephrine from its shelves.","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1676556080/image_1676556080.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1676556080/image_1676556080.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4262259-fda-proposes-removing-oral-decongestant-phenylephrine-otc-meds","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["LU1571399168.USD","LU1585245621.USD","LU0323591593.USD","LU1066051498.USD","BK4588","LU1868836914.USD","HLN","BK4581","LU1059921491.USD","KVUE","SG9999015358.SGD","BK4533","CVS","IE00BSNM7G36.USD","CVS.AU","BK4183","IE000M9KFDE8.USD","LU1868837136.USD","PG","BK4550","LU0689626769.HKD","IE00BZ1G4Q59.USD","BK4504","LU1699723380.USD","IE00BLSP4452.SGD","LU0072461881.USD","LU0234572021.USD","LU1914381329.SGD","LU0211331839.USD","LU1868836591.USD","LU0320765489.SGD","LU2552382132.HKD","IE00BWXC8680.SGD","LU2552382058.USD","IE00BBT3K403.USD","SG9999014542.SGD","LU0162691827.USD","LU0070302665.USD","LU0208291251.USD","LU0096364046.USD","LU1066053197.SGD","SG9999015341.SGD","BK4558","LU1868836757.USD","BK4559","LU2242652126.USD","IE00B3T34201.USD","LU0124676726.USD","LU1280957306.USD","BK4018"],"gpt_icon":0},{"id":"2481193759","title":"Kenvue Inc. (KVUE): Expanded Production and Trusted Brands Drive Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2481193759","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481193759?lang=en_us&edition=fundamental","pubTime":"2024-11-08 02:43","pubTimestamp":1731005014,"startTime":"0","endTime":"0","summary":"We recently published a list of 8 Best Consumer Staples Stocks To Buy Right Now. In this article, we are going to take a look at where Kenvue Inc.  stands against other best consumer staples stocks to buy right now.Consumer spending plays a significant role in the economy, according to the U.S. Bureau of Economic Analysis, in Q2, personal consumption expenditures represented nearly 68% of the US national GDP. As a result, economic growth and decline is often led by consumer spending. However, spending on consumer staples goods tends to be less cyclical due to the low price elasticity of demand and the demand for these goods remains relatively constant regardless of the state of the economy or the cost of the product.The consumer staples sector is comprised of companies that produce and sell essential goods such as food, beverages, household products, and personal care items. This sector is further divided into six industries: beverages, food and staples retailing, food products, househ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xQvJM0YbssUoFewKy7.bDA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/44cb0b0f45ff4cd664ee3d89bdd8eab0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xQvJM0YbssUoFewKy7.bDA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/44cb0b0f45ff4cd664ee3d89bdd8eab0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kenvue-inc-kvue-expanded-production-184334466.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","BK4588","KVUE","BK4585","IE00BFXG1179.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2481806791","title":"Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2481806791","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481806791?lang=en_us&edition=fundamental","pubTime":"2024-11-07 23:57","pubTimestamp":1730995028,"startTime":"0","endTime":"0","summary":"Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in Skin Health and Beauty.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41813370/listerine-and-tylenol-maker-kenvues-q3-earnings-revenue-miss-on-weak-skin-health-and-beauty-sales","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KVUE"],"gpt_icon":0},{"id":"2481518483","title":"Kenvue Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481518483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481518483?lang=en_us&edition=fundamental","pubTime":"2024-11-07 23:07","pubTimestamp":1730992079,"startTime":"0","endTime":"0","summary":"Kenvue Inc reports results for the quarter ended in September 30 - Earnings Summary  Kenvue Inc KVUE.N reported quarterly adjusted earnings of 28 cents per share for the quarter ended September 30, lo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL8N3ME2R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KVUE"],"gpt_icon":0},{"id":"2481009869","title":"Band-Aid, Tylenol parent's sales miss the mark amid weakness in skin health","url":"https://stock-news.laohu8.com/highlight/detail?id=2481009869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481009869?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:49","pubTimestamp":1730987340,"startTime":"0","endTime":"0","summary":"Profit tops expectations, but stock takes a hit as full-year sales growth outlook is trimmed. Shares of Kenvue Inc. leaned lower Thursday, after the consumer-health company, with brands including Band-Aid, Tylenol and Neutrogena, reported third-quarter sales that fell shy of expectations amid weakness in its skin health and beauty product lines.While the company topped quarterly profit expectations and said it was seeing \"early signs of recovery\" in skin health and beauty, the full-year outlook for sales growth was trimmed.Net income for the quarter to Sept. 29 fell to $383 million, or 20 cents a share, from $438 million, or 23 cents a share, in the same period a year ago.Excluding nonrecurring items, such as costs related to the company's separation from Johnson & Johnson  completed in August 2023, adjusted earnings per share of 28 cents was above the FactSet consensus of 27 cents.Net sales slipped 0.4% to $3.899, just shy of the FactSet consensus of $3.920 billion, as a 1.6% decline ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","KVUE"],"gpt_icon":0},{"id":"2481907354","title":"Kenvue Exec Says External Environment Is \"Certainly Not Helping\" Skin Health Unit Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2481907354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481907354?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:28","pubTimestamp":1730986100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nFWN3ME0U3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","IE00BFXG1179.USD","BK4183","BK4585","KVUE","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2481690273","title":"Kenvue Exec Says in Skin Health Category, Whole Industry Is Seeing That the Consumer Remains Cautious in China - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2481690273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481690273?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:28","pubTimestamp":1730986100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nFWN3ME0U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","BK4183","KVUE","IE00BFXG1179.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2481948189","title":"Kenvue (KVUE) Q3 Earnings Surpass Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481948189","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481948189?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:55","pubTimestamp":1730984107,"startTime":"0","endTime":"0","summary":"Kenvue  came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.70%. A quarter ago, it was expected that this consumer health company would post earnings of $0.28 per share when it actually produced earnings of $0.32, delivering a surprise of 14.29%.Over the last four quarters, the company has surpassed consensus EPS estimates four times.Kenvue , which belongs to the Zacks Consumer Products - Staples industry, posted revenues of $3.9 billion for the quarter ended September 2024, missing the Zacks Consensus Estimate by 0.56%. This compares to year-ago revenues of $3.92 billion. The company has topped consensus revenue estimates two times over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact on th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Tw87WEC1wh0JNb8.IBuFMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Tw87WEC1wh0JNb8.IBuFMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kenvue-kvue-q3-earnings-surpass-125507285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ENR","KVUE"],"gpt_icon":0},{"id":"2481903935","title":"Kenvue's Q3 Adjusted Earnings, Net Sales Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2481903935","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481903935?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:13","pubTimestamp":1730981600,"startTime":"0","endTime":"0","summary":"Kenvue  reported Q3 adjusted earnings Thursday of $0.28 per diluted share, down from $0.31 a year earlier.Analysts polled by Capital IQ expected $0.27.Net sales for the quarter ended Sept. 29 were $3.90 billion, compared with $3.92 billion a year earlier.Analysts polled by Capital IQ expected $3.92 billion.The company said it expects to hit the lower end of its full-year net sales growth forecast of 1% to 3%, and reiterated its adjusted EPS guidance of $1.10 to $1.20. Analysts polled by Capital IQ expect an adjusted EPS of $1.14 on revenue of $15.66 billion.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KVUE"],"gpt_icon":0},{"id":"2481018831","title":"Kenvue Inc (KVUE) Q3 2024 Earnings: EPS at $0.20 Misses Estimates, Revenue Slightly Below Expectations at $3.9 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2481018831","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481018831?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:01","pubTimestamp":1730980873,"startTime":"0","endTime":"0","summary":"On November 7, 2024, Kenvue Inc (KVUE, Financial) released its 8-K filing detailing the financial results for the third quarter of 2024. Kenvue, the world's largest pure-play consumer health company, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2588745/kenvue-inc-kvue-q3-2024-earnings-eps-at-020-misses-estimates-revenue-slightly-below-expectations-at-39-billion","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["KVUE"],"gpt_icon":0},{"id":"2481970120","title":"Band-Aid, Tylenol parent tops profit view, but sales fall a bit shy and outlook was trimmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2481970120","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481970120?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:57","pubTimestamp":1730980620,"startTime":"0","endTime":"0","summary":"Shares of Kenvue Inc.  tacked on 0.5% in premarket trading Thursday, after the consumer health company, with brands including Band-Aid and Tylenol, topped third-quarter profit expectations and affirmed its full-year outlook. Net income fell to $383 million, or 20 cents a share, from $438 million, or 23 cents a share, in the same period a year ago. Excluding nonrecurring items, adjusted earnings per share of 28 cents was above the FactSet consensus of 27 cents. Net sales slipped 0.4% to $3.899, just why of the FactSet consensus of $3.920 billion, as a 1.6% decline in volume, driven by weakness in the skin health and beauty and self care business lines, offset a 2.5% increase in price and mix. For 2024, the company said it expects sales growth toward the low end of the previously provided guidance range of 1% to 3%, but still expects adjusted EPS of $1.10 to $1.20. The stock has gained 4.5% year to date through Wednesday, while the S&P 500  has run up 24.3%.This content was created by Ma","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KVUE"],"gpt_icon":0},{"id":"2481430970","title":"Band-Aid, Tylenol Parent Tops Profit View, But Sales Fall A Bit Shy And Outlook Was Trimmed -- MarketWatch","url":"https://stock-news.laohu8.com/highlight/detail?id=2481430970","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481430970?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:57","pubTimestamp":1730980620,"startTime":"0","endTime":"0","summary":"Shares of Kenvue Inc.  tacked on 0.5% in premarket trading Thursday, after the consumer health company, with brands including Band-Aid and Tylenol, topped third-quarter profit expectations and affirmed its full-year outlook. Net income fell to $383 million, or 20 cents a share, from $438 million, or 23 cents a share, in the same period a year ago. Excluding nonrecurring items, adjusted earnings per share of 28 cents was above the FactSet consensus of 27 cents. Net sales slipped 0.4% to $3.899, just why of the FactSet consensus of $3.920 billion, as a 1.6% decline in volume, driven by weakness in the skin health and beauty and self care business lines, offset a 2.5% increase in price and mix. For 2024, the company said it expects sales growth toward the low end of the previously provided guidance range of 1% to 3%, but still expects adjusted EPS of $1.10 to $1.20. The stock has gained 4.5% year to date through Wednesday, while the S&P 500  has run up 24.3%.This content was created by Ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KVUE"],"gpt_icon":0},{"id":"2481523970","title":"Kenvue Expects 2024 Net Sales Growth And Organic Growth Toward The Low End Of Its Outlook Of 1.0%-3.0% And 2.0%-4.0%, Respectively, Reaffirms 2024 Adjusted EPS Of $1.10-$1.20 Versus Consensus Of $1.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2481523970","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481523970?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:52","pubTimestamp":1730980331,"startTime":"0","endTime":"0","summary":"For 2024, assuming an approximately 1% currency headwind, the Company expects Net sales growth and Organic growth toward the low end of its outlook of 1.0%-3.0% and 2.0%-4.0%, respectively. The Company reaffirms its","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41802078/kenvue-expects-2024-net-sales-growth-and-organic-growth-toward-the-low-end-of-its-outlook-of-1-0-3-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KVUE"],"gpt_icon":0},{"id":"2481097773","title":"Kenvue Q3 2024 Adj EPS $0.28 Beats $0.27 Estimate, Sales $3.90B Miss $3.93B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481097773","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481097773?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:46","pubTimestamp":1730980000,"startTime":"0","endTime":"0","summary":"Kenvue (NYSE:KVUE) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.27 by 3.7 percent. This is a 9.68 percent decrease over earnings of $0.31 per share from the same period","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41801939/kenvue-q3-2024-adj-eps-0-28-beats-0-27-estimate-sales-3-90b-miss-3-93b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kenvue Q3 2024 Adj EPS $0.28 Beats $0.27 Estimate, Sales $3.90B Miss $3.93B Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KVUE"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KVUE\",params:#limit:5,,,undefined,":[{"date":"2025-02-12","symbol":"KVUE","amount":0.205,"announcedDate":"2025-01-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-12","defaultRemindTime":1739370600000,"name":"Kenvue Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-26","payableDate":"2025-02-12","currency":"USD","dateTimestamp":1739336400000,"payDate":"2025-02-26"},{"market":"US","date":"2025-02-06","symbol":"KVUE","fiscalQuarterEnding":"2024/12","expectedEps":0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":0.26},{"date":"2024-11-13","symbol":"KVUE","amount":0.205,"announcedDate":"2024-10-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-13","defaultRemindTime":1731508200000,"name":"Kenvue Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-27","payableDate":"2024-11-13","currency":"USD","dateTimestamp":1731474000000,"payDate":"2024-11-27"},{"market":"US","date":"2024-11-07","symbol":"KVUE","fiscalQuarterEnding":"2024/09","expectedEps":0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":0.28},{"date":"2024-08-14","symbol":"KVUE","amount":0.205,"announcedDate":"2024-07-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-14","defaultRemindTime":1723642200000,"name":"Kenvue Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-14","currency":"USD","dateTimestamp":1723608000000,"payDate":"2024-08-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KVUE\",market:\"US\",,,undefined,":[{"executeDate":"2023-08-25","recordDate":"2023-08-28","paymentDate":"2023-09-07","value":0.2,"currency":"USD"},{"executeDate":"2023-11-07","recordDate":"2023-11-08","paymentDate":"2023-11-22","value":0.2,"currency":"USD"},{"executeDate":"2024-02-13","recordDate":"2024-02-14","paymentDate":"2024-02-28","value":0.2,"currency":"USD"},{"executeDate":"2024-05-07","recordDate":"2024-05-08","paymentDate":"2024-05-22","value":0.2,"currency":"USD"},{"executeDate":"2024-08-14","recordDate":"2024-08-14","paymentDate":"2024-08-28","value":0.205,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KVUE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1176,"buy":0.1765,"hold":0.7059,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.7059,"analysts":17,"updateTime":1738987200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KVUE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KVUE","date":"2025-04-03","current":44.29254,"percent":0.993274,"low":19.237339,"twenty":23.024742,"median":25.530862,"eighty":39.009796,"high":44.496653,"avg":29.722427,"sd":7.971663,"marketCap":45621315986},"quantilePoints":[{"date":"2023-05-05","current":24.069042,"twenty":19.237339,"median":19.237339,"eighty":22.136361,"marketCap":50232091600},{"date":"2023-05-12","current":23.53296,"twenty":20.096463,"median":23.711138,"eighty":23.78096,"marketCap":49113286560},{"date":"2023-05-19","current":24.530163,"twenty":23.568596,"median":23.913338,"eighty":24.528349,"marketCap":51194450303},{"date":"2023-05-26","current":23.886065,"twenty":23.599396,"median":23.886065,"eighty":24.528349,"marketCap":49850217325},{"date":"2023-06-02","current":22.933525,"twenty":23.341756,"median":23.786391,"eighty":24.521091,"marketCap":47862267147},{"date":"2023-06-09","current":25.454208,"twenty":23.53296,"median":23.940496,"eighty":24.947466,"marketCap":48082999488},{"date":"2023-06-16","current":26.102981,"twenty":23.586695,"median":24.069042,"eighty":25.454208,"marketCap":49308531933},{"date":"2023-06-23","current":26.913948,"twenty":23.637497,"median":24.530163,"eighty":25.533619,"marketCap":50840447488},{"date":"2023-06-30","current":26.346271,"twenty":23.686762,"median":24.702527,"eighty":26.123255,"marketCap":49768106599},{"date":"2023-07-07","current":25.971199,"twenty":23.730378,"median":25.362975,"eighty":26.269229,"marketCap":49059595655},{"date":"2023-07-14","current":25.748184,"twenty":23.770099,"median":25.433934,"eighty":26.133393,"marketCap":48638318877},{"date":"2023-07-21","current":27.3668,"twenty":23.815374,"median":25.423797,"eighty":26.133393,"marketCap":46934062822},{"date":"2023-07-28","current":27.06533,"twenty":23.869735,"median":25.44914,"eighty":26.409121,"marketCap":46417041322},{"date":"2023-08-04","current":26.786191,"twenty":23.92961,"median":25.494757,"eighty":26.538876,"marketCap":45938317711},{"date":"2023-08-11","current":26.093926,"twenty":24.013071,"median":25.580921,"eighty":26.481103,"marketCap":44751083156},{"date":"2023-08-18","current":25.435158,"twenty":24.051788,"median":25.596127,"eighty":26.466856,"marketCap":43621295434},{"date":"2023-08-25","current":26.417727,"twenty":24.249862,"median":25.599384,"eighty":26.466856,"marketCap":45306402545},{"date":"2023-09-01","current":25.736628,"twenty":24.52472,"median":25.607969,"eighty":26.431126,"marketCap":44138316934},{"date":"2023-09-08","current":23.436522,"twenty":24.521091,"median":25.599384,"eighty":26.417727,"marketCap":40193634379},{"date":"2023-09-15","current":24.273939,"twenty":24.069042,"median":25.569144,"eighty":26.417231,"marketCap":41629805212},{"date":"2023-09-21","current":23.324866,"twenty":23.951382,"median":25.550682,"eighty":26.41083,"marketCap":40002144935},{"date":"2023-09-28","current":22.576773,"twenty":23.800883,"median":25.524482,"eighty":26.404641,"marketCap":38719165657},{"date":"2023-10-06","current":22.063157,"twenty":23.696892,"median":25.48462,"eighty":26.396957,"marketCap":37838314213},{"date":"2023-10-13","current":21.571872,"twenty":23.518336,"median":25.444071,"eighty":26.392179,"marketCap":36995760658},{"date":"2023-10-20","current":22.152481,"twenty":23.328244,"median":25.423797,"eighty":26.367706,"marketCap":37991505768},{"date":"2023-10-23","current":22.040826,"twenty":23.28467,"median":25.423797,"eighty":26.362347,"marketCap":37800016324},{"date":"2023-11-02","current":21.007093,"twenty":22.933525,"median":25.352837,"eighty":26.346271,"marketCap":36153207102},{"date":"2023-11-10","current":21.386523,"twenty":22.420455,"median":25.245343,"eighty":26.283741,"marketCap":36806205533},{"date":"2023-11-17","current":21.820484,"twenty":22.293168,"median":25.150096,"eighty":26.274808,"marketCap":37553053616},{"date":"2023-11-24","current":22.532627,"twenty":22.16588,"median":24.968,"eighty":26.225012,"marketCap":38778650471},{"date":"2023-12-01","current":22.744044,"twenty":22.239573,"median":24.693456,"eighty":26.134237,"marketCap":39142499537},{"date":"2023-12-08","current":23.155751,"twenty":22.239573,"median":24.525627,"eighty":26.104248,"marketCap":39851047718},{"date":"2023-12-15","current":23.433932,"twenty":22.329365,"median":24.117621,"eighty":26.099359,"marketCap":40329796490},{"date":"2023-12-22","current":23.611967,"twenty":22.365328,"median":24.017606,"eighty":26.084994,"marketCap":40636195703},{"date":"2023-12-29","current":23.890148,"twenty":22.398124,"median":23.890148,"eighty":26.071595,"marketCap":41114944474},{"date":"2024-01-05","current":23.255896,"twenty":22.404823,"median":23.890148,"eighty":26.060016,"marketCap":40023397276},{"date":"2024-01-12","current":24.402,"twenty":22.415989,"median":23.994927,"eighty":26.003638,"marketCap":41995842214},{"date":"2024-01-19","current":23.300405,"twenty":22.425266,"median":23.890148,"eighty":25.971161,"marketCap":40099997079},{"date":"2024-01-26","current":23.088988,"twenty":22.432482,"median":23.872457,"eighty":25.886247,"marketCap":39736148013},{"date":"2024-02-02","current":23.244769,"twenty":22.436933,"median":23.782654,"eighty":25.754649,"marketCap":40004247325},{"date":"2024-02-09","current":22.245706,"twenty":22.436933,"median":23.757929,"eighty":25.743562,"marketCap":37016854993},{"date":"2024-02-16","current":21.923471,"twenty":22.413755,"median":23.69333,"eighty":25.716921,"marketCap":36480656369},{"date":"2024-02-23","current":22.084589,"twenty":22.324665,"median":23.667603,"eighty":25.679349,"marketCap":36748755681},{"date":"2024-03-01","current":21.865929,"twenty":22.191019,"median":23.619149,"eighty":25.647303,"marketCap":36384906615},{"date":"2024-03-08","current":22.781683,"twenty":22.152713,"median":23.586695,"eighty":25.640604,"marketCap":37908720649},{"date":"2024-03-15","current":23.092342,"twenty":22.160107,"median":23.51468,"eighty":25.612639,"marketCap":38425657749},{"date":"2024-03-22","current":23.82872,"twenty":22.191019,"median":23.483543,"eighty":25.606903,"marketCap":39650990134},{"date":"2024-03-28","current":24.680157,"twenty":22.211181,"median":23.51468,"eighty":25.602641,"marketCap":41067780703},{"date":"2024-04-05","current":23.207401,"twenty":22.245706,"median":23.52382,"eighty":25.596127,"marketCap":38617115934},{"date":"2024-04-12","current":22.379755,"twenty":22.245706,"median":23.483543,"eighty":25.596127,"marketCap":37239912216},{"date":"2024-04-19","current":22.529337,"twenty":22.185978,"median":23.435227,"eighty":25.569144,"marketCap":37488816513},{"date":"2024-04-26","current":21.884984,"twenty":22.172642,"median":23.411677,"eighty":25.565716,"marketCap":36416613385},{"date":"2024-05-03","current":22.000047,"twenty":22.084589,"median":23.403002,"eighty":25.535648,"marketCap":36608078230},{"date":"2024-05-10","current":26.376176,"twenty":22.085488,"median":23.411677,"eighty":25.569144,"marketCap":39326879019},{"date":"2024-05-17","current":28.974628,"twenty":22.092097,"median":23.42422,"eighty":25.607969,"marketCap":43201170787},{"date":"2024-05-24","current":24.965793,"twenty":22.152481,"median":23.483543,"eighty":25.613807,"marketCap":37223997048},{"date":"2024-05-31","current":24.387881,"twenty":22.153407,"median":23.51468,"eighty":25.609137,"marketCap":36362330450},{"date":"2024-06-07","current":23.925551,"twenty":22.168841,"median":23.559827,"eighty":25.603707,"marketCap":35672997171},{"date":"2024-06-14","current":23.155002,"twenty":22.180644,"median":23.52382,"eighty":25.598733,"marketCap":34524108373},{"date":"2024-06-21","current":24.195244,"twenty":22.196059,"median":23.559827,"eighty":25.596127,"marketCap":36075108250},{"date":"2024-06-28","current":23.655859,"twenty":22.20614,"median":23.559827,"eighty":25.596127,"marketCap":35270886092},{"date":"2024-07-05","current":23.514592,"twenty":22.231896,"median":23.51468,"eighty":25.579937,"marketCap":35060256479},{"date":"2024-07-12","current":23.013735,"twenty":22.245706,"median":23.514592,"eighty":25.567087,"marketCap":34313478760},{"date":"2024-07-15","current":23.553119,"twenty":22.245706,"median":23.514592,"eighty":25.566402,"marketCap":35117700919},{"date":"2024-08-02","current":23.925551,"twenty":22.245706,"median":23.514592,"eighty":25.565716,"marketCap":35672997171},{"date":"2024-08-09","current":36.369353,"twenty":22.287705,"median":23.51468,"eighty":25.596127,"marketCap":40697306315},{"date":"2024-08-16","current":36.917033,"twenty":22.319965,"median":23.553119,"eighty":25.613807,"marketCap":41310159868},{"date":"2024-08-23","current":36.899918,"twenty":22.343464,"median":23.613585,"eighty":25.687361,"marketCap":41291008195},{"date":"2024-08-30","current":37.225103,"twenty":22.379755,"median":23.623095,"eighty":25.785473,"marketCap":41654889993},{"date":"2024-09-06","current":38.525842,"twenty":22.39445,"median":23.655859,"eighty":26.056156,"marketCap":43110417183},{"date":"2024-09-13","current":39.501396,"twenty":22.407056,"median":23.691594,"eighty":26.113523,"marketCap":44202062576},{"date":"2024-09-20","current":39.193327,"twenty":22.418222,"median":23.711138,"eighty":26.274808,"marketCap":43857332452},{"date":"2024-09-27","current":39.586971,"twenty":22.430077,"median":23.759462,"eighty":26.373687,"marketCap":44297820944},{"date":"2024-10-04","current":38.115082,"twenty":22.432482,"median":23.782654,"eighty":26.398878,"marketCap":42650777018},{"date":"2024-10-11","current":36.489158,"twenty":22.441384,"median":23.807555,"eighty":26.448991,"marketCap":40831368029},{"date":"2024-10-18","current":36.711653,"twenty":22.511564,"median":23.886065,"eighty":26.569287,"marketCap":41080339786},{"date":"2024-10-25","current":39.313132,"twenty":22.52918,"median":23.907849,"eighty":26.815415,"marketCap":43991394167},{"date":"2024-10-31","current":39.176212,"twenty":22.529337,"median":23.930104,"eighty":27.011736,"marketCap":43838180778},{"date":"2024-11-08","current":41.345295,"twenty":22.529337,"median":23.994927,"eighty":27.759829,"marketCap":43991394167},{"date":"2024-11-15","current":42.543654,"twenty":22.531311,"median":24.054234,"eighty":31.526506,"marketCap":45266448111},{"date":"2024-11-22","current":43.408582,"twenty":22.532627,"median":24.08185,"eighty":36.157127,"marketCap":46186731681},{"date":"2024-11-29","current":43.390563,"twenty":22.537546,"median":24.131031,"eighty":36.509696,"marketCap":46167559107},{"date":"2024-12-06","current":41.678726,"twenty":22.557664,"median":24.209604,"eighty":36.869111,"marketCap":44346164540},{"date":"2024-12-13","current":40.21916,"twenty":22.621435,"median":24.273939,"eighty":37.009454,"marketCap":42793186016},{"date":"2024-12-20","current":38.939787,"twenty":22.705537,"median":24.387881,"eighty":37.173758,"marketCap":41431933235},{"date":"2024-12-27","current":39.138,"twenty":22.731543,"median":24.414513,"eighty":37.238795,"marketCap":41642831553},{"date":"2025-01-03","current":38.345149,"twenty":22.732917,"median":24.511213,"eighty":37.516058,"marketCap":40799238280},{"date":"2025-01-10","current":38.020801,"twenty":22.741819,"median":24.561762,"eighty":37.673516,"marketCap":40454131941},{"date":"2025-01-17","current":38.182975,"twenty":22.744044,"median":24.680157,"eighty":37.838235,"marketCap":40626685111},{"date":"2025-01-24","current":37.390124,"twenty":22.754314,"median":24.693456,"eighty":37.852342,"marketCap":39783091838},{"date":"2025-01-31","current":39.138,"twenty":22.773474,"median":24.715364,"eighty":37.966743,"marketCap":41642831553},{"date":"2025-02-07","current":36.856017,"twenty":22.785805,"median":24.85021,"eighty":38.020801,"marketCap":37961697272},{"date":"2025-02-14","current":39.927352,"twenty":22.861992,"median":24.977164,"eighty":38.135031,"marketCap":41125172045},{"date":"2025-02-21","current":41.677082,"twenty":22.915403,"median":25.190645,"eighty":38.233429,"marketCap":42927394036},{"date":"2025-02-28","current":42.937971,"twenty":22.92653,"median":25.281878,"eighty":38.384791,"marketCap":44226110260},{"date":"2025-03-07","current":43.012194,"twenty":22.933334,"median":25.393386,"eighty":38.518996,"marketCap":44302559889},{"date":"2025-03-14","current":43.012194,"twenty":22.937849,"median":25.435158,"eighty":38.741491,"marketCap":44302559889},{"date":"2025-03-21","current":43.401865,"twenty":22.972094,"median":25.464345,"eighty":38.84969,"marketCap":44703920440},{"date":"2025-03-28","current":43.605978,"twenty":23.017131,"median":25.515031,"eighty":38.948145,"marketCap":44914156920},{"date":"2025-04-03","current":44.29254,"twenty":23.024742,"median":25.530862,"eighty":39.009796,"marketCap":45621315986}],"updateTime":1743836586373}}}